Tg Therapeutics reported $-40510000 in Pre-Tax Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Ardelyx ARDX:US $ -26.93M 1.14M
Arrowhead Research ARWR:US $ -72.05M 116.41M
Biogen BIIB:US $ 874.8M 28.6M
Curis CRIS:US $ -15.94M 0.17M
Dynavax Technologies DVAX:US $ 129.37M 96.52M
Infinity Pharmaceuticals INFI:US $ -11.99M 0.45M
Intercept Pharmaceuticals ICPT:US $ -20.32M 3.04M
Karyopharm Therapeutics KPTI:US $ -48941000 7.67M
Novartis NOVN:VX SF 4129M 217M
Novavax NVAX:US $ -509.07M 715.14M
Ptc Therapeutics PTCT:US $ -148.7M 26.8M
Spectrum Pharmaceuticals SPPI:US $ -15.39M 24.37M
Tg Therapeutics TGTX:US $ -40.51M 28.5M
Verastem VSTM:US $ -21.95M 4.99M
Ziopharm Oncology ZIOP:US $ -9.79M 2M